Register
Login:
Share:
Email Facebook Twitter

Share Views: HUM CEO updates on Yanfolila and Dugbe Gold Projects. Watch here

Share Views Ep. 19
HUM CEO updates on Yanfolila and Dugbe Gold Projects.


Shire Share Chat (SHP)



Share Price: 4,589.50Bid: 4,589.50Ask: 4,590.00Change: 35.00 (+0.77%)Riser - Shire
Spread: 0.50Spread as %: 0.01%Open: 4,540.00High: 4,625.50Low: 4,510.00Yesterday’s Close: 4,554.50


Share Discussion for Shire


Thread View

Please login or register to post a message on Share Chat.

Posts per page:


samadhi1978
Posts: 406
Premium Chat Member
Off Topic
Opinion:No Opinion
Price:4,989.00
Profit taking
3 Aug '16
will bounce back soon!
 
JR710
Posts: 639
Off Topic
Opinion:No Opinion
Price:4,289.00
The Petition is gaining support
30 May '16
Apologies for board hopping but-
The petition is going quite well; ~5150 signatures so far. Although it really needs a turbo boost.

https://petition.parliament.uk/petitions/112044/sponsors/frRbCOsOLO6QqIN82UOX

This petition was stalled in parliament since 12th Aug 15; finally green lit on 12th feb 2016.
The FCA don't even reply on the matter, now is your chance to have your say.
If you hate seeing buys reported as sells etc!!!!!!
Has already been sent to Martin Lewis, Daily Mail, Moneyweek & Watchdog.

My local MP supported this petition by writing to the petitions committee to help un-stall it.
There’s 650 MP’s in Westminster, So have you written to your MP? 649 to go!

If this petition doesn’t reach 10,000; then imo we might as well have not bothered as it will almost certainly be filed B1N; @ 10,000 the government should respond. We are currently getting approx. 100 new signatures a week, but need 3x that amount to reach the target with only 15 weeks to go.

So – If you haven’t yet signed or indeed have but haven’t passed it on to others, then now’s the time to do so. If each person who has signed can get just one other person to sign then we will double the total immediately. I have posted to all aim listed gas n oilies, currently doing the footsy 100. But I can only do so much to push this. Really need you guys & gals to help. Thanks to all who have signed so far.
faramog
Posts: 186
Off Topic
Opinion:Buy
Price:4,173.00
news
27 Apr '16
Brussels, 27 April 2016 The European Commission has approved under the EU Merger Regulation the acquisition of Baxalta Inc. by Shire plc. Baxalta is a global pharmaceutical company incorporated in the United States. It specialises in rare diseases and advancing innovative therapies in haematology, immunology and oncology. Shire is a Jersey-registered, Irish-headquartered global specialty biopharmaceutical company active in neuroscience, gastrointestinal and internal medicine, ophthalmics and rare diseases. The Commission concluded that the proposed acquisition would raise no competition concerns. Although both companies focus on the development of treatments for specific rare diseases, they target different diseases with dissimilar therapeutic indications and only have in common the fact that a small number of patients suffers from these diseases. Their businesses are therefore complementary. The transaction was examined under the simplified merger review procedure. More information is available on the Commission's competition website, in the public case register under the case number M.7951. - See more at: http://crweworld.com/article/news/26067/mergers-commission-clears-acquisition-of-baxalta-by-shire#sthash.SXT0rMQX.dpuf
faramog
Posts: 186
Off Topic
Opinion:Buy
Price:4,173.00
news
27 Apr '16
Brussels, 27 April 2016 The European Commission has approved under the EU Merger Regulation the acquisition of Baxalta Inc. by Shire plc. Baxalta is a global pharmaceutical company incorporated in the United States. It specialises in rare diseases and advancing innovative therapies in haematology, immunology and oncology. Shire is a Jersey-registered, Irish-headquartered global specialty biopharmaceutical company active in neuroscience, gastrointestinal and internal medicine, ophthalmics and rare diseases. The Commission concluded that the proposed acquisition would raise no competition concerns. Although both companies focus on the development of treatments for specific rare diseases, they target different diseases with dissimilar therapeutic indications and only have in common the fact that a small number of patients suffers from these diseases. Their businesses are therefore complementary. The transaction was examined under the simplified merger review procedure. More information is available on the Commission's competition website, in the public case register under the case number M.7951. - See more at: http://crweworld.com/article/news/26067/mergers-commission-clears-acquisition-of-baxalta-by-shire#sthash.SXT0rMQX.dpuf
mrcautious
Posts: 541
Off Topic
Opinion:No Opinion
Price:4,065.00
Great Potential
5 Apr '16
I have a position in this in my SIPP and trading account, it is still a gift
Rhambo
Posts: 1,770
Off Topic
Opinion:No Opinion
Price:3,634.00
RE: Momentum on Shire (SHP)
18 Mar '16
Looks like there is value in this at these levels.
notgreedy
Posts: 1,028
Off Topic
Opinion:No Opinion
Price:3,717.00
RE: Time to Watch Shire (SHP)
3 Feb '16
Maybe now. I'll be brave and get a bit positive with smallish( parallel) long.
notgreedy
Posts: 1,028
Off Topic
Opinion:No Opinion
Price:3,879.00
RE: Time to Watch Shire (SHP)
28 Jan '16
Not yet. I don't put much value to brokers bs. They are pushing their own positions. On the other hand, today's c r ratings are nothing to shout about. Not that I think shp sp should be any higher any time soon, due to financials trickling down to us pis, but purely cos of necessity and mechanics of volatility, I shall reduce a bit my shorts and start smallish parallel longs for short play. I could be wrong but I still believe sp will come to low £30's in this tax year. Thank you shp bod for your good work.
Exoplanet
Posts: 6
Off Topic
Opinion:No Opinion
Price:4,277.00
I think
13 Jan '16
You've made some good points notgreedy. The big rise today from broker upgrades and perhaps the technicals, has helped to push the price up over+3% and may push on a bit more. Looks overdone Imo, but not going to rush in just yet...
notgreedy
Posts: 1,028
Off Topic
Opinion:No Opinion
Price:4,135.00
RE: Well played
12 Jan '16
Thanks Exoplanet. IMO
1 I compare business model of shp to JE. , Glen, qpp, ....- rush to chase growth by overpaying for acquisitions.
2 shp bod is playing on greed of investors winning against ration - fear. That can and it did work in liquid markets, which is no more.
3 financial ( cash is gone and sp is in big debt or will be when -if merger completed) and accounting ( qpp stile) engendering.
4 falling markets, drying liquidity, fear, panic, profit taking(shp sp more than doubled in 1.5 years?-in my case short from last year), necessity and will of mms - markets- brokers to create volatility will not end.
5 dilution, previously non existing debt cost, potential failed drags, pricing issues, potential futures legal battles that could arise from any or all of issues I mentioned, patent expire ...( GSK as example )...
This is all IMO and not an advice to anyone to go long, short, buy or sell shares. I'm likely to take long at some point as a short play but will be adding short every time I think that market is overreacting. I was short when ABV to was on on a of chance that to will not happen, taking a view then, that loss I could take from those levels v profit should thing get undone was worth taking. It worked. I took a view that sp of £58 was silly and took short again, and again....
This is a summary of what I was talking about on this Bb for the past year or two and not an advice. Gla




Share Price, Share Chat, Stock Market news at lse.co.uk
FREE Member Services
- Setup a personalised Watchlist and Virtual Portfolio.
- Gain access to LIVE real-time Regulatory News (RNS).
- View more Trades, Directors' Deals, and Broker Ratings.
Share Price, Share Chat, Stock Market news at lse.co.uk






Datafeed and UK data supplied by NBTrader and Digital Look. While London South East do their best to maintain the high quality of the information displayed on this site,
we cannot be held responsible for any loss due to incorrect information found here. All information is provided free of charge, 'as-is', and you use it at your own risk.
The contents of all 'Chat' messages should not be construed as advice and represent the opinions of the authors, not those of London South East Limited, or its affiliates.
London South East does not authorise or approve this content, and reserves the right to remove items at its discretion.